Volume 1, Issue 2
Gathering More Evidence
Future Research Initiatives Related to the Management and Treatment of Chronic Disease
Promoting health and reducing the burden of chronic disease and mental illness is an important priority for CIHR. To better focus investments, the organization has recently launched a number of major research initiatives to increase research activity in this area. Known as CIHR Roadmap Signature Initiatives,1 these new investments will help CIHR allocate its resources to make the strongest possible impact on health and health care – today, tomorrow and well into the future.
Roadmap Signature Initiative – Inflammation in Chronic Disease
This initiative aims to develop a unified Canadian strategy on inflammation research that will support the discovery and validation of common biomarkers, therapeutic targets and inflammatory mechanisms amongst chronic diseases, as well as develop prevention and treatment approaches.
Roadmap Signature Initiative – Canadian Epigenetics, Environment and Health Research Consortium
This initiative will ensure that Canada plays a leadership role in the field of epigenetics, which has the potential to transform our ability to 'read' and subsequently manipulate functional states of a genome within specific cell types.
Roadmap Signature Initiative – International Collaborative Research Strategy for Alzheimer's Disease
This initiative will help Canadian researchers engage in large-scale international Alzheimer's research and provide Canadians with rapid access to the latest preventive, diagnostic and treatment approaches to Alzheimer's disease and related dementias.
For More Information:
- The name Roadmap Signature Initiatives is linked to CIHR's five-year strategic plan, Health Research Roadmap: Creating innovative research for better health and health care.